A Study Comparing the Safety and Efficacy of Risankizumab to Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis
Clinical trial NCT03219437 · COMPLETED
Trial details
- NCT number
- NCT03219437
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-30
- Primary completion
- 2021-11-26
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.